Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Clinical results of LHRH antagonist in BPH and prostate cancer

Feb. 10, 1998

Pernasal testosterone: a novel administration route for androgenic substitution

Feb. 9, 1998

Sustiva-containing combinations highly effective in reducing viral load in HIV-infected patients

Feb. 9, 1998

MENT: summary of concept data and preclinical and clinical results

Feb. 9, 1998

Controlled-release melatonin for treating sleep disorders in the elderly

Feb. 9, 1998

Estrogen replacement also a possibility in men?

Feb. 9, 1998

Nitric oxide as a target in stroke therapy

Feb. 6, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

Glaxo Wellcome's new NRTI highlighted at AIDS conference

Feb. 6, 1998

FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial

Feb. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.